StockWaves
  • Home
  • Global Markets
    Global MarketsShow More
    Novo Nordisk provides up battle for Metsera as Pfizer inks B deal
    Novo Nordisk provides up battle for Metsera as Pfizer inks $10B deal
    0 Min Read
    Purchase the weak spot in shares like Tesla and Palantir as bull market has extra room to run, investor says
    Purchase the weak spot in shares like Tesla and Palantir as bull market has extra room to run, investor says
    5 Min Read
    US forces working with Israel on Gaza help, Israeli official says
    US forces working with Israel on Gaza help, Israeli official says
    0 Min Read
    Shopify (SHOP) sees vital alternative for development, right here’s why
    Shopify (SHOP) sees vital alternative for development, right here’s why
    3 Min Read
    2 of my favorite FTSE 100 shares are wanting nice in November
    2 of my favorite FTSE 100 shares are wanting nice in November
    4 Min Read
  • Investment Strategies
    Investment StrategiesShow More
    Tweets of Nithin Kamath’s Tweet and Ashneer Grover Defined
    Tweets of Nithin Kamath’s Tweet and Ashneer Grover Defined
    11 Min Read
    10 Worst Performing Mutual Funds within the Final 1 Yr in 2025 (-16% to -12% Returns)
    10 Worst Performing Mutual Funds within the Final 1 Yr in 2025 (-16% to -12% Returns)
    10 Min Read
    Insurance coverage ought to simply insure
    Insurance coverage ought to simply insure
    0 Min Read
    Why most fund managers path index funds over the long term
    Why most fund managers path index funds over the long term
    0 Min Read
    SIP at Market Highs: Begin Now or Wait?
    SIP at Market Highs: Begin Now or Wait?
    0 Min Read
  • Market Analysis
    Market AnalysisShow More
    Dr. Reddy’s Labs to Orkla India – Prashanth Tapse of Mehta Equities suggests shares to purchase within the quick time period
    Dr. Reddy’s Labs to Orkla India – Prashanth Tapse of Mehta Equities suggests shares to purchase within the quick time period
    6 Min Read
    The Rising Enchantment of Gold IRAs for Trendy Retirement Planning
    The Rising Enchantment of Gold IRAs for Trendy Retirement Planning
    6 Min Read
    GREED & worry: Jefferies sees room to build up gold if costs right
    GREED & worry: Jefferies sees room to build up gold if costs right
    6 Min Read
    2 mid caps that doubled each 4 years and nonetheless stay low-cost
    2 mid caps that doubled each 4 years and nonetheless stay low-cost
    0 Min Read
    Purchase or promote: Sumeet Bagadia recommends three shares to purchase on Monday – 10 November 2025
    Purchase or promote: Sumeet Bagadia recommends three shares to purchase on Monday – 10 November 2025
    7 Min Read
  • Trading
    TradingShow More
    African Union Rejects Trump’s Claims Of Focused Killings In Nigeria, Warns Towards Army Motion
    African Union Rejects Trump’s Claims Of Focused Killings In Nigeria, Warns Towards Army Motion
    2 Min Read
    Nvidia CEO Jensen Huang Hails TSMC Wafer Backing Amid ‘Very Sturdy’ Demand For Blackwell Chips After Trump Bars Gross sales To ‘Different Folks’ – NVIDIA (NASDAQ:NVDA), Micron Expertise (NASDAQ:MU)
    Nvidia CEO Jensen Huang Hails TSMC Wafer Backing Amid ‘Very Sturdy’ Demand For Blackwell Chips After Trump Bars Gross sales To ‘Different Folks’ – NVIDIA (NASDAQ:NVDA), Micron Expertise (NASDAQ:MU)
    3 Min Read
    Pfizer Clinches  Billion Deal To Purchase Weight problems Drug Maker Metsera, Outbidding Novo Nordisk In Fierce Battle For Weight-Loss Market Dominance – Metsera (NASDAQ:MTSR), Eli Lilly (NYSE:LLY)
    Pfizer Clinches $10 Billion Deal To Purchase Weight problems Drug Maker Metsera, Outbidding Novo Nordisk In Fierce Battle For Weight-Loss Market Dominance – Metsera (NASDAQ:MTSR), Eli Lilly (NYSE:LLY)
    3 Min Read
    Palantir CEO Alex Karp Blasts Quick Sellers Once more As Inventory Drops 11% This Week, Deems It ‘Market Manipulation’ – Meta Platforms (NASDAQ:META), NVIDIA (NASDAQ:NVDA)
    Palantir CEO Alex Karp Blasts Quick Sellers Once more As Inventory Drops 11% This Week, Deems It ‘Market Manipulation’ – Meta Platforms (NASDAQ:META), NVIDIA (NASDAQ:NVDA)
    3 Min Read
    Sean Duffy Warns Of 20% Flight Reductions As Shutdown Threatens To Cripple Vacation Journey: ‘Going To Make Choices Based mostly On…’ – American Airways Group (NASDAQ:AAL), Delta Air Traces (NYSE:DAL)
    Sean Duffy Warns Of 20% Flight Reductions As Shutdown Threatens To Cripple Vacation Journey: ‘Going To Make Choices Based mostly On…’ – American Airways Group (NASDAQ:AAL), Delta Air Traces (NYSE:DAL)
    3 Min Read
Reading: Earnings Preview: UnitedHealth appears poised to finish FY24 on a optimistic observe
Share
Font ResizerAa
StockWavesStockWaves
  • Home
  • Global Markets
  • Investment Strategies
  • Market Analysis
  • Trading
Search
  • Home
  • Global Markets
  • Investment Strategies
  • Market Analysis
  • Trading
Follow US
2024 © StockWaves.in. All Rights Reserved.
StockWaves > Global Markets > Earnings Preview: UnitedHealth appears poised to finish FY24 on a optimistic observe
Global Markets

Earnings Preview: UnitedHealth appears poised to finish FY24 on a optimistic observe

StockWaves By StockWaves Last updated: January 9, 2025 4 Min Read
Earnings Preview: UnitedHealth appears poised to finish FY24 on a optimistic observe
SHARE


Contents
OutlookKey Metrics

UnitedHealth Group (NYSE: UNH), a number one supplier of medical insurance and healthcare providers, is anticipated to report fourth-quarter earnings subsequent week. The corporate, a market chief within the nation’s colossal healthcare trade, delivered a blended efficiency in 2024 amid headwinds like Medicare fee cuts and rising healthcare prices.

The diversified firm has a powerful observe report of dividend funds, nearly doubling the payout prior to now 5 years. That makes it a pretty funding for revenue buyers. Rising profitability and the administration’s optimistic earnings outlook for the 12 months recommend extra dividend hikes. In 2024, UnitedHealth’s inventory grew steadily and set a brand new report, however suffered a pointy fall and reversed most of these good points after the tragic assassination of UnitedHealthcare CEO Brian Thompson in early December. Nonetheless, it’s regaining momentum forward of the earnings.

The corporate will publish its fourth-quarter report on Thursday, January 16, at 5:55 am ET. On common, analysts following UnitedHealth predict adjusted revenue of $6.75 per share for the quarter, in comparison with $6.16 per share in This autumn 2023. It’s estimated that complete revenues rose 7.8% year-over-year to $101.78 billion within the ultimate three months of fiscal 2024.

Outlook

Within the September quarter report, the administration mentioned it expects full-year 2024 earnings to be within the vary of $27.50 per share to 27.75 per share, adjusted for one-off objects. On the midpoint, the estimate is increased than the revenue the corporate earned in 2023. Unadjusted revenue is anticipated to be between $15.50 per share and 15.75 per share in FY24.

The enterprise has confronted stress from rising healthcare prices, resulting in elevated declare payouts to clients. The brand new regulation permitting the federal government to instantly negotiate drug costs with pharmaceutical firms to scale back drug prices for Medicare beneficiaries is including to the pressure on revenues. Whereas UnitedHealth has sturdy fundamentals and a wholesome stability sheet, it has a comparatively excessive debt. The excellent news is that the corporate’s money flows have been fairly sturdy.

From UnitedHealth’s Q3 2024 earnings name:

“For over 20 years, there was a bipartisan consensus amongst healthcare consultants and policymakers that value-based care that’s built-in, patient-centered, and outcome-focused care is superior to the usually fragmented and unnecessarily costly fee-for-service system. Throughout 4 presidential administrations, CMS has known as for private-public innovation within the growth of value-based care fashions in Medicare and Medicaid. It supplies higher outcomes for sufferers. It saves cash for the shoppers and taxpayers who fund care.“

Key Metrics

Within the third quarter, revenues grew by 9% to about $100 billion and barely exceeded Wall Avenue’s expectations, persevering with the latest development. All 4 enterprise segments delivered development, translating right into a 9% rise in adjusted earnings to $7.15 per share. Apparently, quarterly earnings beat estimates persistently for over a decade. Internet revenue attributable to the corporate, together with particular objects, elevated to $6 billion or $6.51 per share in Q3 from $5.8 billion or $6.24 per share within the prior-year quarter.

After dropping about 7% prior to now 30 days, UnitedHealth’s inventory traded increased on Wednesday afternoon. The inventory’s present worth nearly matches its worth round three years in the past.

Sign Up For Daily Newsletter

Be keep up! Get the latest breaking news delivered straight to your inbox.

By signing up, you agree to our Terms of Use and acknowledge the data practices in our Privacy Policy. You may unsubscribe at any time.
Share This Article
Facebook Twitter Copy Link Print
Previous Article ‘No Charge Cuts In Q1 2025,’ Strategist Says After Fed’s December Minutes – SPDR S&P 500 (ARCA:SPY) ‘No Charge Cuts In Q1 2025,’ Strategist Says After Fed’s December Minutes – SPDR S&P 500 (ARCA:SPY)
Next Article the most effective free BTC Cloud Mining Choice That Is Environmentally Pleasant And Secure In 2025 the most effective free BTC Cloud Mining Choice That Is Environmentally Pleasant And Secure In 2025
Leave a comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

FacebookLike
TwitterFollow
PinterestPin
InstagramFollow

Subscribe Now

Subscribe to our newsletter to get our newest articles instantly!

Most Popular
Novo Nordisk provides up battle for Metsera as Pfizer inks B deal
Novo Nordisk provides up battle for Metsera as Pfizer inks $10B deal
November 8, 2025
Can Ai be the expansion engine for India’s future financial system?
Can Ai be the expansion engine for India’s future financial system?
November 8, 2025
Purchase the weak spot in shares like Tesla and Palantir as bull market has extra room to run, investor says
Purchase the weak spot in shares like Tesla and Palantir as bull market has extra room to run, investor says
November 8, 2025
African Union Rejects Trump’s Claims Of Focused Killings In Nigeria, Warns Towards Army Motion
African Union Rejects Trump’s Claims Of Focused Killings In Nigeria, Warns Towards Army Motion
November 8, 2025
Winter Session of Parliament to be held from December 1-19
Winter Session of Parliament to be held from December 1-19
November 8, 2025

You Might Also Like

Key takeaways from Apple’s (AAPL) Q1 2025 earnings report
Global Markets

Key takeaways from Apple’s (AAPL) Q1 2025 earnings report

4 Min Read
Oil hunch as Trump's higher-than-expected tariffs anticipated to crimp demand
Global Markets

Oil hunch as Trump's higher-than-expected tariffs anticipated to crimp demand

0 Min Read
Meta in talks over Scale AI funding that might exceed  billion, Bloomberg studies
Global Markets

Meta in talks over Scale AI funding that might exceed $10 billion, Bloomberg studies

0 Min Read
FAST Earnings: Fastenal studies a rise in This autumn 2024 gross sales
Global Markets

FAST Earnings: Fastenal studies a rise in This autumn 2024 gross sales

1 Min Read

Always Stay Up to Date

Subscribe to our newsletter to get our newest articles instantly!

StockWaves

We provide tips, tricks, and advice for improving websites and doing better search.

Latest News

  • About Us
  • Contact Us
  • Privacy Policy
  • Terms Of Service

Resouce

  • Blockchain
  • Business
  • Economics
  • Financial News
  • Global Markets
  • Investment Strategies
  • Market Analysis
  • Trading

Trending

Novo Nordisk provides up battle for Metsera as Pfizer inks $10B deal
Can Ai be the expansion engine for India’s future financial system?
Purchase the weak spot in shares like Tesla and Palantir as bull market has extra room to run, investor says

2024 © StockWaves.in. All Rights Reserved.

Welcome Back!

Sign in to your account

Not a member? Sign Up